Patents by Inventor Eric Eldering

Eric Eldering has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MDM2 INHIBITOR
    Publication number: 20140140988
    Abstract: The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a MDM2 inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a MDM2 inhibitor.
    Type: Application
    Filed: June 13, 2013
    Publication date: May 22, 2014
    Applicant: Roche Glycart AG
    Inventors: ERIC ELDERING, FRANK HERTING, CHRISTIAN KLEIN, MARINUS H.J. VAN OERS
  • C1 inhibitor muteins and uses thereof
    Patent number: 5622930
    Abstract: Compositions consisting of C1 inhibitor muteins having biological activity similar to C1 inhibitor, but with enhanced resistance to proteolytic cleavage thus rendering such muteins suitable as anti inflammatory agents, preferably for the treatment or prevention of sepsis.
    Type: Grant
    Filed: September 5, 1991
    Date of Patent: April 22, 1997
    Assignee: CLB
    Inventors: Eric Eldering, Lucien Aarden